• OPEN AN ACCOUNT
Indian Indices
Sensex
74,294.96 -19.63
( -0.03%)
Global Indices
Nasdaq
51,699.28 -99.76
(-0.19%)
Dow Jones
7,668.45 9.69
(0.13%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,654.81 -161.33
(-1.49%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Godavari Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530317
INE362C01012
71.0541395
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
31.53
122.51
EPS(TTM)
Face Value()
Div & Yield %
3.56
10
0
 

NCL Industries consolidated net profit rises 505.77% in the March 2026 quarter
Jun 01,2026
Net profit of NCL Industries rose 505.77% to Rs 41.98 crore in the quarter ended March 2026 as against Rs 6.93 crore during the previous quarter ended March 2025. Sales rose 6.50% to Rs 399.63 crore in the quarter ended March 2026 as against Rs 375.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 278.53% to Rs 95.39 crore in the year ended March 2026 as against Rs 25.20 crore during the previous year ended March 2025. Sales rose 4.40% to Rs 1422.08 crore in the year ended March 2026 as against Rs 1362.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales399.63375.25 6 1422.081362.10 4
OPM %12.776.27 -13.368.76 -
PBDT58.3828.02 108 202.53120.55 68
PBT43.0113.58 217 147.0466.48 121
NP41.986.93 506 95.3925.20 279